Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma of the Head and Neck
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorIndiana University
About this trial
The purpose of this study is to research if a type of biopsy known as sentinel lymph node biopsy (SLNB) can help in determining the rate of tumor deposits that are hard to detect and identify in node-negative cutaneous squamous cell carcinoma of the head or neck.
Eligibility criteria
Qualifiers
Patients ≥ 18 years old at the time of informed consent
Ability to provide written informed consent and HIPAA authorization
Primary or recurrent invasive cutaneous squamous cell carcinoma of the head or neck, clinically staged T2-T4 based on AJCC staging
Clinically and radiographically regional node-negative (no evidence of regional lymph node metastasis or distant metastasis)
Disqualifiers
Clinical evidence of satellite lesions, in-transit, regional nodal or distant metastases
Known biopsy proven synchronous primary cutaneous squamous cell carcinoma
Pregnant patients
Patients unable to undergo general anesthesia
Trial design
Treatments tested in this trial
- sentinel lymph node biopsy (SLNB)
Treatment groups
94 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov